SFM
GSK icon

Sphera Funds Management’s GSK GSK Stock Holding History

Sphera Funds Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-233,040
Closed -$7K – 154
2014
Q4 		$7K Hold
233,040
– – ﹤0.01% 125
2014
Q3 		$13.4M Buy
233,040
+230,640
+9,610% +$14.1M 1.65% 16
2014
Q2 		$698K Hold
2,400
– – 0.17% 83
2014
Q1 		$878K Buy
+2,400
New +$162K 0.2% 94

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Sphera Funds Management's GSK Position: Q2 2026 in Review

Sphera Funds Management reduced its GSK (GSK) stake by 16% in Q2 2026, selling an estimated $1.06M and leaving 102,000 shares worth $5.35M. The position accounts for 0.7% of the portfolio, ranked #47.

Sphera Funds Management first reported a position in GSK in Q4 2013 and has held it in 28 quarters since. The position peaked at $34.7M in Q3 2018. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Sphera Funds Management held 102,000 shares of GSK worth $5.35M as of Q2 2026.
  • Sphera Funds Management sold 20,000 GSK shares in Q2 2026, an estimated $1.06M.
  • GSK made up 0.7% of Sphera Funds Management's portfolio in Q2 2026, its #47 holding.
  • Sphera Funds Management first reported a position in GSK in Q4 2013 and has held it in 28 quarters since.
  • Sphera Funds Management's GSK position peaked at $34.7M in Q3 2018.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.